Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04376632 · ClinicalTrials.gov registry record · NA

Diets Enriched With Pecans

A NA study of Obesity and Hypercholesterolemia, sponsored by University of Georgia.

Completed
Registry status
NA
Development phase
124
Enrollment target
1
Study location

NCT04376632 is a NA study of Obesity and Hypercholesterolemia that has completed, run by University of Georgia. The registered enrollment target is 124 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04376632, a NA study of Obesity and Hypercholesterolemia, has completed, sponsored by University of Georgia.

COMPLETED
Registry status
NA
Development phase
124 participants
Enrollment target
1
Study location

Study Summary

Background: Previous studies report that daily pecan consumption reduces cholesterol in healthy adults while promoting weight maintenance. Purpose: To examine the impact of daily pecan consumption with and without dietary substitution instructions for an 8-week period on markers of health in adults at risk for cardiovascular disease.

Interventions

  • DIETARY_SUPPLEMENT Pecan ADD
  • DIETARY_SUPPLEMENT Pecan SUB

Study Locations (1)

Georgia

  • University of Georgia- Department of Foods and Nutrition - Athens

Trial Details

FieldValue
Enrollment Target 124 participants
Start Date 2018-08-10
Est. Completion 2021-06-01
Phase NA

Sponsor

University of Georgia

59 total trials

What the Registry Record Tells You About NCT04376632

The ClinicalTrials.gov registry entry for NCT04376632 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Pecan ADD is the first listed.

NCT04376632 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04376632 about?

NCT04376632 is a clinical study titled "Diets Enriched With Pecans". Background: Previous studies report that daily pecan consumption reduces cholesterol in healthy adults while promoting weight maintenance. Purpose: To examine the impact of daily pecan consumption with and without dietary substitution instructions for an 8-week period on markers of health in adults...

What is the current status of trial NCT04376632?

This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2018-08-10. Estimated completion is 2021-06-01.

What conditions does trial NCT04376632 study?

This clinical trial studies the following conditions: Obesity, Hypercholesterolemia.

What interventions are being tested in trial NCT04376632?

The interventions under investigation include: Pecan ADD (DIETARY_SUPPLEMENT), Pecan SUB (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04376632?

This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04376632 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.